REG - Abbott Laboratories - Abbott Laboratories Files Form 8-K <Origin Href="QuoteRef">ABT.N</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
RNS Number : 0615VAbbott Laboratories22 October 2014Notification to RNS
Company: Abbott Laboratories
TIDM: ABT
Headline: Abbott Laboratories Files Form 8-K
Abbott Laboratories (the "Company")
22 October 2014
Abbott Laboratories Files Form 8-K
The Company informs its shareholders that on 22 October 2014, in accordance with the U.S. Securities Exchange Act of 1934, as amended, a Current Report on Form 8-K ("Form 8-K") was filed with the U.S. Securities and Exchange Commission ("SEC"). The Form 8-K can be found on the SEC website at http://www.sec.gov.
A copy of the Form 8-K has been submitted to the National Storage Mechanism on the date of this announcement and is, or will shortly be, available for inspection at http://www.morningstar.co.uk/uk/NSM.
Issued by: Abbott Laboratories
CONTACT: Financial, Brian Yoor, +1-847-937-6343, or Tina Ventura, +1-847-935-9390, or Media, Melissa Brotz, +1-847-935-3456, or Scott Stoffel, +1-847-936-9502.
This information is provided by RNSThe company news service from the London Stock ExchangeENDSTRFEDFAEFLSELS
Recent news on Medtronic
See all newsRCS - Cydar Ltd - First patient treated in Medtronic collaboration
AnnouncementRCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
AnnouncementRCS - Cydar Ltd - Cydar Medical raises $11.5m (£9.3m) in Series A
AnnouncementREG - Baillie GiffordJapan - Net Asset Value(s) <Origin Href="QuoteRef">BGFD.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
AnnouncementREG - Goldman Sachs (EPT) Greene King PLC - Form 8.5 (EPT/RI) - Amendment <Origin Href="QuoteRef">GNK.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
Announcement